RetractedArticleMolecular cancer therapeutics2010

ErbB-inhibitory protein: a modified ectodomain of epidermal growth factor receptor synergizes with dasatinib to inhibit growth of breast cancer cells.

Jyoti Nautiyal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.